The type 1 insulin-like growth factor receptor pathway.
Research conducted over the past two decades has shown the importance of the type 1 insulin-like growth factor receptor (IGF1R) in tumorigenesis, metastasis, and resistance to existing forms of cancer therapy. The IGF1R itself has only recently been accepted as a credible treatment target, however,...
Príomhchruthaitheoirí: | Chitnis, M, Yuen, J, Protheroe, A, Pollak, M, Macaulay, V |
---|---|
Formáid: | Journal article |
Teanga: | English |
Foilsithe / Cruthaithe: |
2008
|
Míreanna comhchosúla
Míreanna comhchosúla
-
Type 1 insulin-like growth factor receptor translocates to the nucleus of human tumor cells.
de réir: Aleksic, T, et al.
Foilsithe / Cruthaithe: (2010) -
Validation of the type 1 insulin-like growth factor receptor as a therapeutic target in renal cancer.
de réir: Yuen, J, et al.
Foilsithe / Cruthaithe: (2009) -
Validation of the type 1 insulin-like growth factor receptor as a therapeutic target in renal cancer
de réir: Yuen, J, et al.
Foilsithe / Cruthaithe: (2009) -
Targeting the type 1 insulin-like growth factor receptor as a treatment for cancer.
de réir: Yuen, J, et al.
Foilsithe / Cruthaithe: (2008) -
The type 1 insulin-like growth factor receptor is over-expressed in bladder cancer.
de réir: Rochester, M, et al.
Foilsithe / Cruthaithe: (2007)